Weroha SJ

No ORCID on file · 4 papers in corpus
review 2025
JAMA ·doi:10.1001/jama.2025.9495

IMPORTANCE: Ovarian cancer is the eighth most common cause of cancer and cancer death in women worldwide. In 2022, ovarian cancer was diagnosed in approximately 324 398 individuals, and 206 839 died of ovarian cancer worldwide. In 2025, it …

2022
Cancer research communications ·doi:10.1158/2767-9764.crc-22-0122

Targeting glutamine metabolism has emerged as a novel therapeutic strategy for several human cancers, including ovarian cancer. The primary target of this approach is the kidney isoform of glutaminase, glutaminase 1 (GLS1), a key enzyme in …

2020
Oncogene ·doi:10.1038/s41388-020-01451-4

A major clinical challenge of ovarian cancer is the development of malignant ascites accompanied by widespread peritoneal metastasis. In ovarian clear cell carcinoma (OCCC), a challenging subtype of ovarian cancer, this problem is compounde…

2017
Oncotarget ·doi:10.18632/oncotarget.16781

Gene fusions play a critical role in some cancers and can serve as important clinical targets. In epithelial ovarian cancer (EOC), the contribution of fusions, especially by histological type, is unclear. We therefore screened for recurrent…